Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Cynamon

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Vaccines|September 8, 2015
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo PersistenceCarolyn M Shoen, Michelle S DeStefano, Cynthia C Hager, et al.
Biochemical Pharmacology|December 8, 2011
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureusMihai Ciustea, Sara Mootien, Adriana E Rosato, et al.
Biochemical Pharmacology|May 18, 2013
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinonesYashang Lee, Sara Mootien, Carolyn Shoen, et al.
European Journal of Medicinal Chemistry|June 16, 2009
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazidMichael J Hearn, Michael H Cynamon, Michaeline F Chen, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Vaccines|September 8, 2015
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo PersistenceCarolyn M Shoen, Michelle S DeStefano, Cynthia C Hager, et al.
Biochemical Pharmacology|December 8, 2011
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureusMihai Ciustea, Sara Mootien, Adriana E Rosato, et al.
Biochemical Pharmacology|May 18, 2013
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinonesYashang Lee, Sara Mootien, Carolyn Shoen, et al.
European Journal of Medicinal Chemistry|June 16, 2009
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazidMichael J Hearn, Michael H Cynamon, Michaeline F Chen, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Pageof 3